MeSH Review:
Eosinophils
DeCoursey,
Morgan,
Cherny,
Wills-Karp,
Luyimbazi,
Xu,
Schofield,
Neben,
Karp,
Donaldson,
Rothenberg,
Hogan,
Wills-Karp,
Gerwin,
Gonzalo,
Lloyd,
Coyle,
Reiss,
Banu,
Wang,
Xu,
Avraham,
Engelhardt,
Springer,
Gutierrez-Ramos,
- Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Garcia-Zepeda, E.A., Rothenberg, M.E., Ownbey, R.T., Celestin, J., Leder, P., Luster, A.D. Nat. Med. (1996)
- Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Tai, P.C., Spry, C.J., Peterson, C., Venge, P., Olsson, I. Nature (1984)
- The pathobiology of bronchial asthma. Arm, J.P., Lee, T.H. Adv. Immunol. (1992)
- Prolonged eosinophil accumulation in allergic lung interstitium of ICAM-2 deficient mice results in extended hyperresponsiveness. Gerwin, N., Gonzalo, J.A., Lloyd, C., Coyle, A.J., Reiss, Y., Banu, N., Wang, B., Xu, H., Avraham, H., Engelhardt, B., Springer, T.A., Gutierrez-Ramos, J.C. Immunity (1999)
- A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Hogan, S.P., Mishra, A., Brandt, E.B., Royalty, M.P., Pope, S.M., Zimmermann, N., Foster, P.S., Rothenberg, M.E. Nat. Immunol. (2001)
- Cellular localization of interleukin-5 expression in rectal carcinoma with eosinophilia. Tajima, K., Yamakawa, M., Inaba, Y., Katagiri, T., Sasaki, H. Hum. Pathol. (1998)
- The eosinophil. Rothenberg, M.E., Hogan, S.P. Annu. Rev. Immunol. (2006)
- Immunologic basis of antigen-induced airway hyperresponsiveness. Wills-Karp, M. Annu. Rev. Immunol. (1999)
- The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Ye, B.H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., de Waard, R., Leung, C., Nouri-Shirazi, M., Orazi, A., Chaganti, R.S., Rothman, P., Stall, A.M., Pandolfi, P.P., Dalla-Favera, R. Nat. Genet. (1997)
- A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Tavernier, J., Devos, R., Cornelis, S., Tuypens, T., Van der Heyden, J., Fiers, W., Plaetinck, G. Cell (1991)
- Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. Hertzman, P.A., Blevins, W.L., Mayer, J., Greenfield, B., Ting, M., Gleich, G.J. N. Engl. J. Med. (1990)
- An etiological role for aeroallergens and eosinophils in experimental esophagitis. Mishra, A., Hogan, S.P., Brandt, E.B., Rothenberg, M.E. J. Clin. Invest. (2001)
- Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. Wardlaw, A.J., Moqbel, R., Cromwell, O., Kay, A.B. J. Clin. Invest. (1986)
- Isolation of human eosinophil phospholipase D. Kater, L.A., Goetzl, E.J., Austen, K.F. J. Clin. Invest. (1976)
- Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). Ohno, I., Lea, R.G., Flanders, K.C., Clark, D.A., Banwatt, D., Dolovich, J., Denburg, J., Harley, C.B., Gauldie, J., Jordana, M. J. Clin. Invest. (1992)
- Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Weller, P.F., Lee, C.W., Foster, D.W., Corey, E.J., Austen, K.F., Lewis, R.A. Proc. Natl. Acad. Sci. U.S.A. (1983)
- Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice. Cheng, J., Turksen, K., Yu, Q.C., Schreiber, H., Teng, M., Fuchs, E. Genes Dev. (1992)
- GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Kulessa, H., Frampton, J., Graf, T. Genes Dev. (1995)
- Disruption of fas receptor signaling by nitric oxide in eosinophils. Hebestreit, H., Dibbert, B., Balatti, I., Braun, D., Schapowal, A., Blaser, K., Simon, H.U. J. Exp. Med. (1998)
- Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. Pazdrak, K., Olszewska-Pazdrak, B., Stafford, S., Garofalo, R.P., Alam, R. J. Exp. Med. (1998)
- Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. Weber, M., Uguccioni, M., Baggiolini, M., Clark-Lewis, I., Dahinden, C.A. J. Exp. Med. (1996)
- Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticaria. Soter, N.A., Wasserman, S.I., Austen, K.F., McFadden, E.R. N. Engl. J. Med. (1980)
- Electron currents generated by the human phagocyte NADPH oxidase. Schrenzel, J., Serrander, L., Bánfi, B., Nüsse, O., Fouyouzi, R., Lew, D.P., Demaurex, N., Krause, K.H. Nature (1998)
- The voltage dependence of NADPH oxidase reveals why phagocytes need proton channels. DeCoursey, T.E., Morgan, D., Cherny, V.V. Nature (2003)
- Total eosinophil counts in the management of bronchial asthma. Horn, B.R., Robin, E.D., Theodore, J., Van Kessel, A. N. Engl. J. Med. (1975)
- Eosinophils cocultured with endothelial cells have increased survival and functional properties. Rothenberg, M.E., Owen, W.F., Silberstein, D.S., Soberman, R.J., Austen, K.F., Stevens, R.L. Science (1987)
- Brominating oxidants generated by human eosinophils. Weiss, S.J., Test, S.T., Eckmann, C.M., Roos, D., Regiani, S. Science (1986)
- Blockade of eosinophil migration and airway hyperresponsiveness by cPLA2-inhibition. Myou, S., Sano, H., Fujimura, M., Zhu, X., Kurashima, K., Kita, T., Nakao, S., Nonomura, A., Shioya, T., Kim, K.P., Munoz, N.M., Cho, W., Leff, A.R. Nat. Immunol. (2001)
- Interleukin-13: central mediator of allergic asthma. Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L., Donaldson, D.D. Science (1998)
- Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. Ponath, P.D., Qin, S., Post, T.W., Wang, J., Wu, L., Gerard, N.P., Newman, W., Gerard, C., Mackay, C.R. J. Exp. Med. (1996)
- Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. Dahinden, C.A., Geiser, T., Brunner, T., von Tscharner, V., Caput, D., Ferrara, P., Minty, A., Baggiolini, M. J. Exp. Med. (1994)
- Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. Bochner, B.S., Luscinskas, F.W., Gimbrone, M.A., Newman, W., Sterbinsky, S.A., Derse-Anthony, C.P., Klunk, D., Schleimer, R.P. J. Exp. Med. (1991)
- Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3. Cuvelier, S.L., Patel, K.D. J. Exp. Med. (2001)
- Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. Gavett, S.H., O'Hearn, D.J., Li, X., Huang, S.K., Finkelman, F.D., Wills-Karp, M. J. Exp. Med. (1995)
- Human eosinophils express transforming growth factor alpha. Wong, D.T., Weller, P.F., Galli, S.J., Elovic, A., Rand, T.H., Gallagher, G.T., Chiang, T., Chou, M.Y., Matossian, K., McBride, J. J. Exp. Med. (1990)
- Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis. Gladue, R.P., Carroll, L.A., Milici, A.J., Scampoli, D.N., Stukenbrok, H.A., Pettipher, E.R., Salter, E.D., Contillo, L., Showell, H.J. J. Exp. Med. (1996)
- Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. Forssmann, U., Uguccioni, M., Loetscher, P., Dahinden, C.A., Langen, H., Thelen, M., Baggiolini, M. J. Exp. Med. (1997)